R&D Pipeline

Pipeline (2021-2030)

Gastrointestinal - Small molecules (2)

Modality Indication Targets Stage Company Project No. Detail
1 Construction of a new paradigm for gallstone treatment
Small molecules Cholelithiasis Gallstone Candidate Surginex RS-2022-00167125
2 Lead identification for functional dyspepsia and cancer cachexia using small molecule compound targeting ghrelin receptor
Small molecules Dyspepsia Ghrelin receptor Hit Kyungpook National University HN21C0438